Collaborative work on evaluation of ovarian toxicity 7) Effects of 2- or 4- week repeated dose studies and fertility study of cyclophosphamide in female rats

Journal of Toxicological Sciences

Volumn 34, Issue 1 SPEC. ISS., 2009, Pages

  Sato, Makoto ^a   Shiozawa, Kei ^a   Uesugi, Toru ^a   Hiromatsu, Riki ^a   Fukuda, Meiko ^a   Kitaura, Keisuke ^a   Minami, Takanori ^a   Matsumoto, Satoshi ^a  

^a Tokushima Research Institute   (Japan)

Author keywords

Cyclophosphamide; Fertility study; Ovarian toxicity; Rat

Indexed keywords

CYCLOPHOSPHAMIDE; ALKYLATING AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATROPHY; CESAREAN SECTION; CONTROLLED STUDY; CORPUS LUTEUM; ESTRUS CYCLE; FEMALE; FEMALE FERTILITY; HISTOPATHOLOGY; MALE; MATING; MORPHOLOGY; NONHUMAN; OVARY; OVARY FOLLICLE ATRESIA; PREGNANCY; RAT; REPRODUCTIVE TOXICITY; ANIMAL; ANIMAL EMBRYO; BODY WEIGHT; CHEMICALLY INDUCED DISORDER; DRUG ADMINISTRATION; DRUG EFFECT; EATING; EMBRYO DEATH; FERTILITY; HEALTH CARE ORGANIZATION; INTRAPERITONEAL DRUG ADMINISTRATION; JAPAN; METABOLISM; METHODOLOGY; NIDATION; ORGAN SIZE; OVARY FOLLICLE; PATHOLOGY; SPRAGUE DAWLEY RAT; TOXICITY TESTING; UTERUS; VAGINA;

RATTUS;

ANIMALS; ANTINEOPLASTIC AGENTS, ALKYLATING; BODY WEIGHT; CYCLOPHOSPHAMIDE; DRUG ADMINISTRATION SCHEDULE; EATING; EMBRYO IMPLANTATION; EMBRYO LOSS; EMBRYO, MAMMALIAN; ESTROUS CYCLE; FEMALE; FERTILITY; INJECTIONS, INTRAPERITONEAL; JAPAN; MALE; ORGAN SIZE; OVARIAN FOLLICLE; OVARY; PREGNANCY; PUBLIC-PRIVATE SECTOR PARTNERSHIPS; RATS; RATS, SPRAGUE-DAWLEY; SOCIETIES, SCIENTIFIC; TOXICITY TESTS; UTERUS; VAGINA;

EID: 64949142502     PISSN: 03881350     EISSN: 18803989     Source Type: Journal    
DOI: 10.2131/jts.34.s83     Document Type: Article

References (8)

1. Ataya, K. and Ramahi-Ataya, A. (1993): Reproductive performance of female rats treated with cyclophosphamide and/or LHRH agonist. Reprod. Toxicol., 7, 229-235.
2. Jarrell, J., Young Lai, E.V., A. McMahon, R.B.A., Belbeck, L. and O'Connell G. (1987): Ovarian toxicity of cyclophosphamide alone and in combination with ovarian irradiation in the rat. Cancer Res., 47, 2340-2343.
3. Mattison, D.R., Shiromizu, K., Pendergrass, J.A. and Thorgeirsson, S.S. (1983): Ontogeny of ovarian glutathione and sensitivity to primordial oocyte destruction by cyclophosphamide. Pediatr. Pharmacol, 3, 49-55.
4. Pedersen, T. and Peters, H. (1968): Proposal for a classification of oocytes and follicles in the mouse ovary. J. Reprod. Fertil., 17, 555-557.
5. Plowchalk, D.R. and Mattison D.R. (1992): Reproductive toxicity of cyclophosphamide in the C57BL/6N mouse: 1. effects on ovarian structure and function. Reprod.Toxicol., 6, 411-421.
6. Shiromizu, K., Thorgeirsson, S.S. and Mattison, D.R. (1984): Effect of cyclophosphamide on oocyte and follicle number in Sprague-Dawley rats, C57BL/6N and DBA/2N mice. Pediatr. Pharmacol. 4, 213-21.
7. Tanaka, S., Kawashima, K., Naito, K., Usami, M., Nakadate, M., Imaida, K., Takahashi, M., Hayashi, Y., Kurokawa, Y. and Tobe, M. (1992): Combined Repeat Dose and Reproductive/Developmental Toxicity Screening Test (OECD): familiarization using cyclophosphamide. Fundam. Appl. Toxicol., 18, 89-95.
8. Wise, L.D., Spence, S., Saldutti, L.P and Kerr, J.S. (2008): Assessment of female and male fertility in sprague-dawley rats administered vorinostat, a histone deacetylase inhibitor. Birth Defects Res. B. Dev. Reprod. Toxicol., 83, 19-26.